U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07096310) titled 'Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients' on July 04.
Brief Summary: The aim of this work is to evaluate the efficacy associated with Meropenem(example of carbapenems) as initial therapy for sepsis in burn patients compared with Pipracillin/Tazobactam (example of non carbapenem beta lactam antibiotics).
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Sepsis
Intervention:
DRUG: Meropenem I.V. 2g as a 3 hour infusion every 8 hours
Non C group will receive non Carbapenems (Tazocin) 4.5 gm IV slow infusion over 20 minutes every 8 hours per day
DRUG: Tazocin (...